Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Processa Pharmaceuticals (PCSA)

Processa Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PCSA
DateTimeSourceHeadlineSymbolCompany
11/10/202214:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
05/10/202221:41Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:PCSAProcessa Pharmaceuticals Inc
03/10/202221:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
03/10/202221:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
03/10/202221:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
15/09/202213:30GlobeNewswire Inc.Processa Pharmaceuticals Provides Update on Enrollment Across all Clinical ProgramsNASDAQ:PCSAProcessa Pharmaceuticals Inc
07/09/202213:30GlobeNewswire Inc.Processa Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 12-14, 2022NASDAQ:PCSAProcessa Pharmaceuticals Inc
07/09/202211:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCSAProcessa Pharmaceuticals Inc
23/08/202221:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
16/08/202213:30GlobeNewswire Inc.Processa Pharmaceuticals Appoints Khoso Baluch and James Neal to its Board of Directors and Justin Yorke to Chairman of the BoardNASDAQ:PCSAProcessa Pharmaceuticals Inc
13/08/202212:31TipRanksAnalysts Offer Insights on Healthcare Companies: SELLAS Life Sciences Group (SLS) and Processa Pharmaceuticals (PCSA)NASDAQ:PCSAProcessa Pharmaceuticals Inc
12/08/202215:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCSAProcessa Pharmaceuticals Inc
12/08/202214:30GlobeNewswire Inc.Processa Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:PCSAProcessa Pharmaceuticals Inc
09/08/202221:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
09/08/202221:30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
09/08/202221:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
09/08/202221:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
09/08/202221:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
09/08/202221:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
09/08/202221:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
09/08/202221:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
05/08/202220:00GlobeNewswire Inc.Processa Pharmaceuticals to Host Conference Call to Discuss Its Second Quarter 2022 Results and Provide 2nd Half Clinical Pipeline Update on August 11, 2022, at 4:30 p.m. ESTNASDAQ:PCSAProcessa Pharmaceuticals Inc
04/08/202214:30GlobeNewswire Inc.Processa Pharmaceuticals Announces Launch of Website to Increase Awareness of Ulcerative Necrobiosis Lipoidica and to Inform Patients of the ongoing Phase 2B Study of PCS499NASDAQ:PCSAProcessa Pharmaceuticals Inc
03/08/202221:00GlobeNewswire Inc.Processa Pharmaceuticals Announces Launch of Website (www.Necrobiosislipoidicastudy.com) to Increase Awareness of Ulcerative Necrobiosis Lipoidica and to Inform Patients of the ongoing Phase 2B Study of PCS499NASDAQ:PCSAProcessa Pharmaceuticals Inc
25/07/202221:49Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCSAProcessa Pharmaceuticals Inc
14/07/202220:53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCSAProcessa Pharmaceuticals Inc
12/07/202213:30GlobeNewswire Inc.Processa Pharmaceuticals to Present at the World Orphan Drug Congress USA, July 11-13, 2022NASDAQ:PCSAProcessa Pharmaceuticals Inc
11/07/202221:44Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PCSAProcessa Pharmaceuticals Inc
05/07/202222:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
31/05/202213:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PCSAProcessa Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PCSA